Equities

Merit Medical Systems Inc

Merit Medical Systems Inc

Actions
  • Price (EUR)45.60
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change80.95%
  • Beta--
Data delayed at least 15 minutes, as of Nov 26 2020.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

  • Revenue in USD (TTM)963.79m
  • Net income in USD-29.43m
  • Incorporated1987
  • Employees6.36k
  • Location
    Merit Medical Systems Inc1600 W Merit PkwySOUTH JORDAN 84095-2416United StatesUSA
  • Phone+1 (801) 253-1600
  • Fax+1 (801) 253-1652
  • Websitehttps://www.merit.com/
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.